TAFI meets the sticky ends

Thrombosis and Haemostasis

Volumn 85, Issue 1, 2001, Pages 1-2

  Booth, N A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; CARBOXYPEPTIDASE B; FIBRIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN C; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN;

BLOOD CLOTTING; CARDIOVASCULAR RISK; CROSS LINKING; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MENOPAUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RISK FACTOR; VEIN THROMBOSIS;

EID: 0035164257     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612653     Document Type: Note

References (20)

1. TAFI
2. The plasma carboxypeptidases and the regulation of the plasminogen system
3. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis
4. Molecular transport during fibrin clot lysis
5. Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma
6. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin
7. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex
8. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact pathway of coagulation
9. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma
10. Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
11. Plasma TAFI antigen variation in healthy subects
12. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation
13. Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage
14. Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor
15. Characterization of plasmin-mediated activation of plasma procarboxypeptidase B; modulation by glycosaminoglycans
16. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promelyocytic leukaemia
17. Regulation of fibrinolytic activity by localization of inhibitors to fibrin(ogen)
18. A novel approach to arterial thrombolysis
19. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model
20. Consequences of inhibition of plasma carboxypeptidase B on in vivo thrombolysis, thrombosis and haemostasis